Problems in pharmacological evaluation of potential antiparkinson agents.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002375:Catalepsy / Q000188:drug therapy; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation / Q000379:methods; D004359:Drug Therapy, Combination; D006801:Humans; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects
D000929:Antidepressive Agents, Tricyclic; D000978:Antiparkinson Agents; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine